Has Megan McCrea, PA received payments from drug or device companies?

Yes. Drug and device makers reported $4,715 in general payments to Megan McCrea, PA across 188 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Megan McCrea, PA did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Megan McCrea, PA come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Megan McCrea, PA

Physician Assistant · Quincy, MANPI 1548822323

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,175 of the $4,715 with a category attached, or 88.5%. 21 manufacturers reported payments, led by AbbVie at 26.8% of the total. Among physician assistant clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,715in general payments, 2019–2025

Across 188 payments — averaging $25.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Johnson & Johnson$976
Incyte Corporation$847
E.r. Squibb & Sons, L.L.C.$367
Janssen Scientific Affairs, LLC$225
Lilly USA, LLC$181
plus $856 from 15 others

What the payments were for

Food & beverage$4,17589%
Education$54011%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	48	$1,263
Johnson & Johnson	34	$976
Incyte Corporation	42	$847
E.r. Squibb & Sons, L.L.C.	18	$367
Janssen Scientific Affairs, LLC	2	$225
Lilly USA, LLC	8	$181
LEO Pharma Inc.	7	$156
Sanofi-aventis U.S. LLC	2	$145
Sanofi	1	$105
Pfizer	5	$84
Verrica Pharmaceuticals Inc.	3	$56
Biofrontera Inc.	3	$51
Galderma Laboratories, L.p.	3	$49
UCB, Inc.	2	$41
Novartis	2	$37
Boehringer Ingelheim	2	$37
VYNE Pharmaceuticals Inc.	2	$30
Amgen	1	$20
Arcutis Biotherapeutics, Inc.	1	$18
Sun Pharmaceutical Industries Inc.	1	$14
Helsinn Therapeutics (U.S.), Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Skyrizi$510
Tremfya$469
OPZELURA$237
Sotyktu$112
Humira$109
DUPIXENT$105

How this compares

$4,715 in reported general payments places this provider in the 95th percentile of 3,507 physician assistant providers in Massachusetts.

See all physician assistant providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$105,393

Medicare patients

290

Services billed

2,976

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tacrolimus	18	$2,424
Clobetasol Propionate	29	$2,197
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc	56	$1,763
Ketoconazole	100	$1,469
Fluorouracil	24	$1,297
Tretinoin	32	$1,193
Metronidazole	28	$1,011
Fluocinonide	20	$877
Triamcinolone Acetonide	64	$563
Doxycycline Monohydrate	19	$227
Mupirocin	22	$163
Nystatin	12	$120
ValacyclovirValacyclovir Hcl	17	$101
Hydrocortisone	25	$92

Paid to pharmacies, not to this prescriber.

Other physician assistant in Quincy

David PeckhamQuincy$61K
Jessica BahrosQuincy$25K
Jie ChenQuincy$22K
Christopher MasseyWilbraham$190K
Lizabeth O ConnorEverett$182K
Kimberly ComeauSwampscott$120K
Stacey PanasciSpringfield$113K
Jason RandWaltham$99K
Karen ChunEast Boston$70K
Leslie SmithSpringfield$49K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →